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ABSTRACT—The neutrophil-to-lymphocyte ratio (NLR) is an inflammation score recognized as associated with outcome.
Although inflammation has been shown to correlatewith the development of acute-on-chronic liver failure (ACLF),we sought to
investigate the role of NLR in predicting 90-daymortality in cirrhotic patients experiencing ACLF.We performed a retrospective
cohort study involving a total of 108 consecutive cirrhotic patients admitted in the intensive care unit (ICU). NLR, clinical and
biological datawere recorded. Of the total, 75 patients had ACLF. The 90-daymortality rate was 53%. ACLF patients displayed
higher NLR values in comparison with cirrhotic patients without ACLF throughout the ICU stay. NLR proved more elevated in
nonsurvivors ACLF patients, with mortality correlating with increasing quartiles of NLR. On multivariable Cox regression
analysis, NLR was found to be a predictor of mortality along with the Sequential Organ Failure Assessment (SOFA) score and
mechanical ventilation requirement. The model for end-stage liver disease (MELD) score was not predictive of 90-days
mortality. Performance analysis revealed an area under curve of 0.71 [95% confidence interval: 0.59–0.82] regarding NLR
capacity to predict 90-days mortality. When including NLR, SOFA score, and mechanical ventilation requirement into the final
model, the area under curve was significantly higher (0.81 [95% confidence interval: 0.72–0.91]). These findings suggest that
NLR is associated with mortality in ACLF patients admitted to the ICU. Combining NLR, SOFA score, and the need for
mechanical ventilation could be a useful prognostic tool to identify ACLF patients at a higher risk of mortality.
KEYWORDS—Cirrhosis, Chronic Liver Failure-Sequential Organ Failure Assessment, liver failure, model for end-stage liver
disease, mortality, organ failure, Sequential Organ Failure Assessment
ABBREVIATIONS—MV—mechanical ventilation; NLR—neutrophil-to-lymphocyte ratio; SOFA—Sequential Organ Failure
Assessment Score
INTRODUCTION
The neutrophil-to-lymphocyte ratio (NLR) is an easily acces-
sible biomarker for assessing inflammatory status. It has been
shown to be predictive of poor outcome in a variety of diseases,
such as cardiovascular disease (1), cancer (2), and postoperative
infection (3). In cirrhosis, NLR is a recognized predictor of
survival in patients with hepatocarcinoma (4) or hepatitis B
virus (HBV) infection, as well as in patients awaiting trans-
plantation (5, 6). Moreover, it has been shown that in uncom-
plicated cirrhosis, higher NLR could predict mortality
independently of the model for end-stage liver disease (MELD)
and Child-Pugh scores (7).
Although acute decompensation (AD) refers to the develop-
ment of 1 or more cirrhotic complications, acute-on-chronic
liver failure (ACLF) is defined as an acute liver function
deterioration leading to extra-hepatic organ failure (OF) and
short-term mortality (8, 9). Despite presenting similar precipi-
tating events, some patients recover whereas others progress to
ACLF. The underlying mechanisms of ACLF are not yet fully
understood (10). In the CANONIC study (CLIF Acute-On-
Chronic Liver Failure in Cirrhosis), white blood cell (WBC)
count and plasma C-reactive protein (CRP) level were shown to
be higher in patients with ACLF than in those without (11). In
addition, WBC count was independently associated with ACLF
occurrence, number of failing organs, and mortality rate. Based
on these findings, the body’s systemic inflammatory response
seems to play a pivotal role in ACLF development.
The pathogenesis of systemic inflammation in ACLF is
indeed complex. The release of pathogen-associated-molecular
patterns (PAMPs) by bacteria has been suggested as a possible
mechanism, yet only a third of ACLF patients have been
documented harboring bacterial infections (8). In addition to
this, excessive inflammation may also result from nonbacterial
endogenous mediators (8, 12). Hence, the initial level of
systemic inflammation following the precipitating event could
favor a shift toward excessive persistent inflammation, leading
to organ dysfunction (13–15). Supporting this hypothesis,
evidence is growing of systemic inflammatory response corre-
lating with the outcome (16–18).
Despite its recognized role in ACLF pathogenesis, systemic
inflammation proves difficult to assess in cirrhotic patients,
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while identifying readily available surrogate markers is still
challenging (19–20). Furthermore, given that clinical and
biological signs can overlap between AD and ACLF, early
assessment and risk stratification is crucial.
This study sought to investigate whether initial inflammation
measured by NLR is associated with the ACLF occurrence and
predictive of 90 days mortality in a cohort of consecutive
cirrhotic patients hospitalized in an ICU due to cirrhosis-
related complications.
PATIENTS AND METHODS
We performed a retrospective observational cohort study in a tertiary, 22-
bed, mixed intensive care unit (ICU) at Saint-Luc university hospital. This
report was written in accordance with the STrengthening the Reporting of
OBservational checklist for observational studies in Epidemiology (STROBE)
statement (21). The study sample consisted of consecutive patients admitted to
the ICU within the preceding 18 months for cirrhosis-related complications.
Institutional approval was provided by the Saint Luc University Hospital Ethics
Committee (Reference: 2014/546; Chairman: Prof J-M Maloteaux), and our
study complied with the Helsinki Declaration. A waiver was obtained for
written informed consent in view of the study’s retrospective design. To ensure
confidentiality, patient data were anonymously recorded in the final database, in
accordance with Belgian law.
Clinical diagnosis and variable selection
Patients were included if the diagnosis of cirrhosis was histologically proven or
clearly considered on the basis of biological, clinical, and radiological features.
Patients with documented chronic hematological disorder, aged younger than
18 years, presenting with human immunodeficiency virus (HIV) infection or
active malignancy, including hepatic carcinoma, were excluded from the analysis.
Medical histories, including any relevant comorbidities and causes and history of
liver disease, were taken on inclusion. Reasons for admission and all following
medical events during the ICU hospitalization were carefully noted. Survival data
were recorded at 28 days, 90 days and 1 year.
Liver failure severity on admission was assessed using the MELD and Child-
Pugh scores, with critical illness evaluated using the SOFA score. Likewise, as
proposed by Arroyo et al. (8), ACLF was defined as an AD of cirrhosis
accompanied by OF. AD was determined according to the CANONIC study
criteria and refers to development of ascites over 2 weeks, new-onset encepha-
lopathy, gastrointestinal hemorrhage or bacterial infection (11). Organ dys-
functions (hemodynamics, respiratory, coagulation, brain, kidney, liver) were
identified using the CLIF consortium organ failure score (8) as follows:
hypotension requiring vasopressors, PaO2/FiO2 ratio <200, international nor-
malized ratio (INR) 2.5, grade (West-Haven) 3–4 encephalopathy, creatinine
2 mg/dL (or requirement of renal replacement therapy), bilirubin>12 mg/dL.
Finally, severity was stratified by taking into account the number of OFs:
grade 1 (1 OF), grade 2 (2 OFs) and grade 3 (3 to 6 OFs) (11). Bacterial infection
was diagnosed when a focus of infection was clinically identified on ICU
admission associated with positive microbiological samples or biological signs
of infection (polymorphonuclear leucocytes >250/mm3 in ascitic fluid) in the
case of spontaneous bacterial peritonitis. Study data were collected and
managed using Research Electronic Data Capture (REDCap) tools hosted at
the Saint Luc university hospitals (22).
Laboratory diagnosis
Leukocyte count was part of the routine ICU analyses. All venous blood
samples were processed in a blood analyzer (Sysmex [TOA Medical Electron-
ics, Kobe, Japan]) to determine complete blood cell counts and differential
leukocyte counts. We recorded neutrophil and lymphocyte counts for the first
5 days after admission and calculated the NLR by dividing the neutrophil count
by the lymphocyte count. Other laboratory tests were also recorded, such as
blood chemistry, CRP, and hemostasis. Serum CRP level was assessed by
immunoturbidimetric assay (Beckman Coulter DxC, Inc., Fullerton, Calif). All
results from microbiological samples (blood, urine, ascites, and swab cultures)
performed during hospitalization were registered.
Statistical analysis
All analyses were conducted using SPSS 21 software (SPSS software [IBM
Corp. 2011, IBM SPSS Statistics for Windows, Version 21.0, Armonk, NY:
IBM Corp]), with graphs drawn using Graphpad Prism 5.0 (GraphPad Software,
La Jolla, Calif). Continuous variables were expressed as mean 1 standard
deviation (SD) or median with interquartile ratio (IQR), and categorical
variables as counts and percentages. Categorical variables were analyzed using
Chi-squared test or Fisher’s exact test. Continuous variables were analyzed
using unpaired t test or Mann-Whitney U test, according to statistical distribu-
tion. The data were subjected to the Kolmogorov-Smirnov normality test and
Bartlett’s test for homogeneity of variance. To test the difference between
means in the AD and ACLF groups according to the presence of infection or
survival, 2-way analysis of variance (ANOVA) with F test was performed,
followed by post-hoc multiple comparisons with Bonferroni correction. Sur-
vival curves were generated across NLR quartiles using the Kaplan-Meier
method, compared by log-rank test. In order to find factors influencing survival,
a Cox proportional hazards model was built. Variables with a P< 0.20 in
univariable analysis were entered into a forward selection procedure based on
the likelihood ratio, after checking the proportional hazard assumption for each
variable and log-linearity. Finally, receiver-operating characteristic (ROC)
curves were generated to assess the accuracy of NLR in predicting mortality.
To this end, a logistic regression model was built as follows: all the variables
significant in the univariable analyses were entered into a multivariable logistic
regression with a backward elimination procedure, based on the likelihood
ratio. The results were expressed as odds ratio (OR) with 95% confidence
intervals (95% confidence interval [CI]). Areas under the receiving operator
curve (AUROC) were compared using the method of Hanley and McNeil (23).
All tests were 2-sided, with significance set at the 0.05 probability level.
RESULTS
Patient features
In total, 108 cirrhotic patients were enrolled in the study.
Three were excluded from analysis, owing to chronic lymphoid
leukemia. The overall characteristics of the included patients
are presented in Table 1. The main cause of cirrhosis was
alcohol abuse, and the foremost clinical events for ICU admis-
sion were bacterial infection (n¼ 45) followed by gastrointes-
tinal hemorrhage (n¼ 43). The majority of patients had severe
liver disease with a meanSD MELD score of 22 9, AD
patients exhibiting 14.7 4, and ACLF 24.6 9.5 (P< 0.001).
Infection source was documented in 41 patients (91%) and
microorganisms were detected in 77% of patients (Supplemen-
tal Digital Content, Appendix 1, http://links.lww.com/SHK/
A636). Spontaneous bacterial peritonitis and pneumonia were
the most reported infections and blood cultures were positive in
13 patients (29%). Escherichia coli was the most prevalent
bacteria (27%) followed by Staphylococcus aureus (25%).
Depending on the number of failing organs (11), ACLF was
classified as Grade 1 (n¼ 48), Grade 2 (n¼ 21), or Grade 3
(n¼ 6). The meanSD SOFA score was 8.4 2.9, being
significantly higher in the ACLF group compared with the
AD group (Table 1). Upon admission, respiratory failure was
observed in 31 patients (29%) displaying a PaO2/FiO2 ratio
<300 mmHg and in 11 patients (10.5%) with severe hypoxemia
(PaO2/FiO2 ratio <200). In total, mechanical ventilation was
provided to 55 patients (51%) during their ICU hospitalization.
Initially, 37 patients presented acute renal failure, whereas renal
replacement therapy was required in 26 patients (25%).
Association between NLR and mortality
The median NLR value for the entire cohort was high,
notably 8.5 (IQR: 5–17). In total, 42 patients (40%) had died
by Day 28. The overall mortality rate was 44% (n¼ 46) at 90
days, and 45% (n¼ 47) at 1 year post-ICU admission. Overall,
40 patients died in the ACLF group (53%), of whom 38 by day
28, versus 7 in the AD group. In those with ACLF, nonsurvivors
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exhibited higher SOFA score values in comparison with sur-
vivors whereas MELD score was not statistically different
between both the groups (Fig. 1A). NLR at admission was
higher in those admitted for bacterial infection (median [IQR]:
16 [8–28] vs. 8 [5–16], P< 0.001). For patients with bacterial
infection on admission, CRP was higher in both the AD and
ACLF groups, compared with those without infection (Fig. 1B).
However, CRP values were not significantly different between
survivors and non survivors (Fig. 1C).
Patients presenting with ACLF displayed significantly
higher NLR than the AD patients throughout the ICU stay
except for day 4 (Fig. 1D). In the ACLF patients, comparing
survivors from nonsurvivors, a lowering of NLR values was
observed in the survivors group. The median NLR values
decreased from 13 (IQR: 6–18) to 7.8 (IQR: 6–13) at day
5. In contrast, NLR was significantly higher in nonsurvivors
from 18 to 24 hours following ICU admission and remained
higher until day 5 (Fig. 1E). Since a significant difference of
NLR values was found from this time and because this was the
highest NLR value, we therefore predefined this window of
interest to compare survivors from non survivors. Additional
laboratory data are provided in Supplemental Digital Content
(Appendix 2, http://links.lww.com/SHK/A637).
For the entire cohort, there was a significant increase in
mortality depending on the NLR quartile, as shown in the
survival curves (Fig. 2). When considering the ACLF group, a
similar observation could be made with patients in the first
quartile, who displayed the highest probability of survival,
whereas patients in the fourth quartile exhibited the lowest
survival probability.
Additionally, in order to account for potential confounders,
we conducted a Cox regression analysis for 90-day mortality,
adjusting for relevant co-variables. In univariate analysis, NLR,
SOFA score, renal replacement therapy and mechanical venti-
lation were identified as significant risk factors associated with
a shorter time to death (Table 2). Multivariable model revealed
that NLR was an independent predictor of mortality (adjusted
hazard ratio [HR]: 1.02; [95% CI: 1.01–1.03], P¼ 0.009).
Other variables associated with death in the multivariable
analysis were the SOFA score and mechanical ventilation
(Table 2).
In unadjusted logistic regression, there was a statistical
relationship between high NLR and 90 days mortality
(Fig. 3A). Following multivariate adjustment, NLR along with
the SOFA score and mechanical ventilation requirement were
independently associated with 90 days mortality (Fig. 3B).
Performance analysis of NLR
A performance analysis revealed an area under curve (AUC)
of 0.71 ([95% CI: 0.59–0.82], P¼ 0.002) as to the NLR
TABLE 1. Clinical characteristics of total cohort and patients with acute decompensation and acute with acute-on-chronic liver failure
Variables Total cohort (n¼105) AD (n¼30) ACLF (n¼75) P
Age (year) 5810 6011 5811 0.36
Male sex, n (%) 72 (69) 20 (66) 52 (70) 0.79
Cause of cirrhosis (n)
Alcohol 65 18 47 0.8
HBV virus 6 1 5 0.67
HCV virus 11 4 7 0.72
Alcoholþ virus 8 0 8 0.1
Other* 15 2 13 0.22
MELD score 229 14.74 24.69.5 <0.001
SOFA score 8.42.9 62 9.32.7 <0.001
SOFA CLIF score 9.81.9 81.2 10.81.6 <0.001
Child-Pugh classes (A–B–C), n 5–42–58 3–16–11 2–26–47 0.03
Child-Pugh score 102 8.81.7 10.22 0.001
Ascites, n (%) 75 (72) 14 (46) 60 (80) 0.005
Precipiting event (n)
Bacterial infection 45 6 39 0.002
Gastrointestinal bleeding 43 20 23 0.001
Toxic or alcoholic hepatitis 4 1 3 0.87
Encephalopathy 7 2 5 0.99
Other† 6 3 3 0.20
Organ failure‡
Liver, n (%) 20 (19) — 20 (19)
Hemodynamic, n (%) 15 (14) — 15 (14)
Lung, n (%) 11 (10.5) — 11 (10.5)
Kidney, n (%) 39 (37) — 39 (37)
Cerebral, n (%) 12 (11) — 12 (11)
Coagulation, n (%) 13 (12) — 13 (12)
Renal replacement therapy, n (%) 26 (25) 1 (3.3) 25 (33) <0.01
Global mortality, n (%) 47 (45) 7 (23) 40 (53) 0.005
Values are mean standard deviation or number of patients (n) and percentages (%).
ACLF indicates acute-on-chronic liver failure; AD, acute decompensation; SOFA CLIF, Sequential Organ Failure Assessment Chronic Liver Failure.
*Refers to nonalcoholic fatty liver disease, biliary, auto-immune.
†Ascites with paracentesis and occurrence of acute renal failure.
‡Organ failure defined according to CLIF consortium organ failure score.
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capacity to predict mortality at 90 days (Fig. 3C). The most
discriminant NLR value to predict 90-day mortality was 6.2,
with a sensitivity of 90% and specificity of 60%. The AUCs for
other variables, such as MELD score or CRP, were not signifi-
cant (0.59 [95% CI: 0.46–0.72], P¼ 0.18 and 0.51 [95% CI:
0.56–0.80], P¼ 0.92), whereas the AUC for the SOFA score
was 0.69 (95% CI: 0.57–0.81; P¼ 0.004). The AUC for a
predictive model associating NLR, SOFA score, and mechani-
cal ventilation requirement was 0.81 ([95% CI: 0.72–0.91];
P¼ 0.001). The pairwise comparison of AUROCs revealed a
FIG. 2. Kaplan-Meier survival analysis across quartiles of neutrophil-to-lymphocyte ratio. Survival was estimated with Kaplan-Meier method stratified
on the basis of NLR in all cohort (A) and ACLF patients (B). Quartiles of NLR are indicated on the graph. ACLF indicates acute-on-chronic liver failure; NLR,
neutrophil-to-lymphocyte ratio.
FIG. 1. Severity scores, neutrophil-to-lymphocyte ratio evolution and C-reactive protein. (A) SOFA and MELD scores among survivors and
nonsurvivors, ‘‘*’’ indicates values statistically different between survivors and nonsurvivors; (B) CRP values in patients with AD and ACLF, ‘‘*" indicates values
statistically different between patients presenting a bacterial infection or not; (C) CRP values in survivors and nonsurvivors; (D) evolution of NLR over the first
5 days after admission in patients with AD and ACLF—0h: value at admission, 18–24 h: 18 to 24 hours after admission, ‘‘*’’ indicates values statistically different
between AD and ACLF; (E) evolution of NLR over the first 5 days after admission according to the survival in ACLF patients, ‘‘*’’ indicates values statistically
different between survivors and nonsurvivors. ACLF indicates acute-on-chronic liver failure; AD, acute decompensation; CRP, C-reactive protein; MELD, model for
end-stage liver disease; NLR, neutrophil-to-lymphocyte ratio; SOFA, Sequential Organ Failure Assessment.
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statistically significant difference between the model associat-
ing the 3 variables and that, which included solely NLR
(P¼ 0.001).
DISCUSSION
In this study, we examined NLR’s ability to predict prognosis
in a cohort of cirrhotic patients admitted to the ICU for acute
cirrhotic complications. The main finding of our analysis
revealed that a high NLR value was associated with mortality
among those developing ACLF, whereas SOFA score and
mechanical ventilation requirement were also significant inde-
pendent predictors of mortality. A second crucial finding was
that the NLR value was higher in nonsurvivor ACLF patients
compared with AD patients. In ACLF patients, this independent
association was not seen with CRP levels.
FIG. 3. Logistic regression model predicting 90-days mortality and receiver-operating characteristic curves for estimated models. (A) univariable
logistic regression analysis; (B) multivariable logistic regression analyses in ACLF patients; and (C) ROC curves were obtained to quantify the performance of
multivariable logistic regression models for 90-days mortality. The curves demonstrated better accuracy for the model combining NLR, SOFA score and
mechanical ventilation requirement (red line)—AUC 0.81 [95%CI: 0.72–0.91]P¼0.001—than themodel using only NLR (gray line)—AUC of 0.73 [95%CI: 0.59–
0.82] P¼0.002). The logistic regression equation for the model combining NLR, SOFA score, and mechanical ventilation and resulting in the red ROC curve is
shown in the graph. ACLF indicates acute-on-chronic liver failure; AUC, area under curve; CI, confidence interval; MV, mechanical ventilation; NLR, neutrophil-to-
lymphocyte ratio; ROC, receiver operating characteristic; SOFA, Sequential Organ Failure Assessment score.
TABLE 2. Cox regression analysis for variables associated with 90 days mortality in patients with acute-on-chronic liver failure
Univariable Multivariable
Variable HR 95% CI P HR 95% CI P
NLR 1.02 1.01–1.03 0.01 1.02 1.01–1.03 0.009
MELD score 1.03 0.99–1.07 0.09
SOFA score 1.30 1.12–1.50 <0.001 1.23 1.07–1.41 0.004
Age 0.98 0.96–1.01 0.22
Sex 0.99 0.51–1.95 0.98
Bacterial infection 1.37 0.74–2.56 0.31
Bleeding 1.02 0.51–2.10 0.96
Encephalopathy 0.69 0.34–1.38 0.29
RRT 2.10 1.10–3.80 0.02
Mechanical ventilation 4.10 1.93–8.64 <0.001 3.11 1.43–6.73 0.004
Hemoglobin 0.96 0.81–1.15 0.71
CRP 0.97 0.91–1.03 0.27
CI indicates confidence interval; CRP, C-reactive protein; HR, hazard ratio; MELD, model for end-stage liver disease; NLR, neutrophil-to-lymphocyte
ratio; RRT, renal replacement therapy; SOFA, Sequential Organ Failure Assessment.
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Association between NLR and outcome
Numerous studies have highlighted the association
between high NLR values and outcome, irrespective of
whether patients underwent AD or ACLF (7, 24), whereas
our study was specifically focused on ACLF needing to be
admitted in the ICU. To date, only few studies have investi-
gated whether early NLR is predictive of short and medium-
term mortality, specifically during ACLF. Those studies have
focused on particular conditions such as HBV infection,
hepatocarcinoma (25) or patients with low severity awaiting
transplantation (26). One of those has so far identified the
relationship between NLR and outcome in patients who
developed ACLF in an HBV setting (5). This study compared
NLR values between patients displaying chronic hepatitis,
defining ACLF according to the recommendations of the
Asian Pacific Association for the study of the liver. In
contrast, we determined ACLF according to the new classi-
fication proposed by Arroyo et al. (8) taking into account
organ failure, with our entire cohort comprising critically ill
patients. Moreover, main causes for decompensation in our
study were bleeding or bacterial infection. Our results dem-
onstrate that NLR was higher in ACLF group in comparison
with the AD patients. In addition, we showed that patients
developing ACLF with NLR values >6.5 within the first
24 hours displayed a higher risk for mortality at 90 days. This
observation is consistent with previous reports analyzing
cases of both acute-complication and clinically stable cir-
rhosis. As such, an NLR value >5 was found correlating with
high mortality in patients listed for liver transplantation (6).
In another retrospective study, stable cirrhotic patients exhib-
iting NLR values exceeding 4.39 had a lower survival
probability (7). It has also been shown that patients
experiencing cirrhosis-related complications, such as uncon-
trolled ascites or variceal bleeding, exhibit NLR values
ranging from 4.9 to 8.1 (according to the presence of
infection), and these values were predictive of early mortality
in Child-Pugh C patients (24). More broadly speaking, NLR
on admission in a large cohort of unselected ICU patients
was shown to correlate with mortality. Survival was stratified
according to NLR quartiles, with increased mortality found
correlating with increasing quartiles of NLR (27, 28). In our
study, this trend was also observed across the distribution of
NLR. Patients exhibiting values in the highest NLR quartile
experienced the worst survival.
Acute-on-chronic liver failure and inflammation
Although our data suggest that NLR proves to be a predictive
biomarker in a setting of cirrhosis-related critical illness, the
association between elevated NLR and poor prognosis is still
poorly understood. The current hypothesis is that NLR reflects
the severity of the underlying acute systemic inflammation
following the primary damage. In the setting of ACLF, Moreau
et al. showed that leukocyte count was an independent predic-
tor of mortality in ACLF (11, 17). Accordingly, systemic
inflammation is common during stable cirrhosis independently
of overt infection. This could be explained by high circulatory
endotoxin levels activating the inflammatory pathways and
recruiting neutrophils (29, 30). Furthermore, inflammation
plays a role in exacerbation of cirrhosis, with systemic inflam-
mation response shown to correlate with portal-hypertension-
related complications and organ dysfunction (13). This sup-
ports the hypothesis that the relationship between elevated
NLR and mortality could reflect the contribution of systemic
inflammation to the ACLF outcome. In this setting, NLR could
indicate the severity of the primary damage and provide
information on how the immune system reacts. In our cohort,
the difference in NLR values was due to the significantly
higher neutrophil count in the ACLF group. This seems in line
with the trend between increased leucocytes count and severity
of ACLF demonstrated by Moreau et al. (11). Given this is in
line with an excessive immune response, it is hypothesized that
patients displaying a more significant immune response are
more at risk for developing ACLF (8, 17, 31). Similarly, it has
recently been shown in stable cirrhotic patients with low
MELD scores that NLR correlated with low-density granulo-
cytes having proinflammatory features (26). Such immature
neutrophils have been recognized as a hallmark of sepsis (32,
33).
Impact of infection
In line with previous works proving the capacity of NLR and
CRP to predict infection (24, 27), our study revealed both
markers to be enhanced in the group with bacterial infection at
admission. However, CRP proved unable to predict mortality in
ACLF patients. The independent prognostic added value of the
NLR is also in agreement with results from noncirrhotic
postoperative patients (3). Nevertheless, it is crucial to note
that CRP was examined only at admission. Contrarily to our
data, CRP has already been shown to predict short-term mor-
tality when persistently elevated throughout ICU hospitaliza-
tion (16, 18, 34).
NLR as risk factor independent of the MELD score
Finally, we observed that the prognostic value of NLR in
ACLF patients was independent of the MELD score. This raises
concern about inflammation staging in acutely ill patients
developing ACLF. In our cohort, patients undergoing ACLF
were predominantly admitted to the ICU following bacterial
infection or an alteration of tissue homeostasis during hemor-
rhage. In both cases, ACLF and organ failure occur through an
exaggerated inflammatory response (8, 17).
In this line, NLR was recognized as a risk factor. Since SOFA
score and the need for mechanical ventilation were also identi-
fied as risk factors, combining them with NLR interestingly
improved the accuracy of the prediction, as shown by the ROC
curves analysis. Thus, such a model could helpfully help
clinicians to stratify the prognosis of ACLF patients. While
the Chronic Liver Failure-Sequential Organ Failure Assess-
ment (CLIF-SOFA) score has been developed to take into
account specific cirrhotic features (11), we carried out a second
multivariable analysis introducing CLIF-SOFA instead of just
the SOFA score as a co-variable. With this adjustment, NLR,
CLIF-SOFA, and mechanical ventilation requirement were still
recognized as independent risk factors for mortality (Supple-
mental Digital Content, Appendix 3, http://links.lww.com/
SHK/A638).
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Strength and limitations
Some limitations of our study must be considered. First, the
diagnostic performance of NLR alone assessed by an AUC of
71% is relatively limited. In addition to this, we showed that
NLR level could vary on a wide range and then be difficult to
interpret as a single value. However, NLR needs to be consid-
ered as a part of various elements used to establish the outcome,
as shown in our model where we combined NLR with MV and
SOFA. We also demonstrated that in nonsurvivors ACLF
patients, NLR remained elevated in the time-course of ICU
stay. This confirms that repeated values are also of interest.
Second, owing to our retrospective design used, our study
findings would benefit from an external validation using a
prospective approach. Nonetheless, our findings point out the
relationship between NLR and early mortality in a cohort of
advanced cirrhosis patients, the large majority of whom
experienced ACLF.
Third, although we emphasized that NLR was higher in the
group of patients with ACLF, as well as those who did not
survive, we did not clarify whether the systemic inflammatory
response directly contributed to hepatic function deterioration.
Moreover, the relationship between NLR and mechanisms of
organ dysfunction is not strongly supported solely on the basis
of our data. Indeed, given the retrospective design of our work,
the available inflammation markers are CRP and WBC count.
Identifying the cytokines involved in the immune response
leading to NLR disturbances, such as interleukin-17, could be
of interest (35).
CONCLUSIONS
NLR may have some potential as an additional tool in
combination with SOFA score and requirement of mechanical
ventilation, to identify ACLF patients with a higher risk of early
mortality.
In this way, our data suggest that this prognostic marker
could be regarded as an indicator of excessive inflammation
underlying advanced cirrhosis.
Nevertheless, further prospective studies are warranted to shed
light on the relationship with systemic inflammatory response.
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